Cargando…

Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery

High-throughput omics experiments provide a wealth of data for exploring biomedical questions and for advancing translational research. However, despite this great potential, results that enter the clinical practice are scarce even twenty years after the completion of the human genome project. For t...

Descripción completa

Detalles Bibliográficos
Autor principal: Emmert-Streib, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587237/
https://www.ncbi.nlm.nih.gov/pubmed/36271093
http://dx.doi.org/10.1038/s41540-022-00251-8
_version_ 1784813862698090496
author Emmert-Streib, Frank
author_facet Emmert-Streib, Frank
author_sort Emmert-Streib, Frank
collection PubMed
description High-throughput omics experiments provide a wealth of data for exploring biomedical questions and for advancing translational research. However, despite this great potential, results that enter the clinical practice are scarce even twenty years after the completion of the human genome project. For this reason in this paper, we revisit problems with scientific discovery commonly summarized under the term reproducibility crisis. We will argue that the major problem that hampers progress in translational research is threefold. First, in order to establish biological foundations of disorders or general complex phenotypes, one needs to embrace emergence. Second, there seems to be confusion about the underlying hypotheses tested by omics studies. Third, most contemporary omics studies are designed to perform what can be seen as incremental corroborations of a hypothesis. In order to improve upon these shortcomings, we define a severe testing framework (STF) that can be applied to a large number of omics studies for enhancing scientific discovery in the biomedical sciences. Briefly, STF provides systematic means to trim wild-grown omics studies in a constructive way.
format Online
Article
Text
id pubmed-9587237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95872372022-10-23 Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery Emmert-Streib, Frank NPJ Syst Biol Appl Article High-throughput omics experiments provide a wealth of data for exploring biomedical questions and for advancing translational research. However, despite this great potential, results that enter the clinical practice are scarce even twenty years after the completion of the human genome project. For this reason in this paper, we revisit problems with scientific discovery commonly summarized under the term reproducibility crisis. We will argue that the major problem that hampers progress in translational research is threefold. First, in order to establish biological foundations of disorders or general complex phenotypes, one needs to embrace emergence. Second, there seems to be confusion about the underlying hypotheses tested by omics studies. Third, most contemporary omics studies are designed to perform what can be seen as incremental corroborations of a hypothesis. In order to improve upon these shortcomings, we define a severe testing framework (STF) that can be applied to a large number of omics studies for enhancing scientific discovery in the biomedical sciences. Briefly, STF provides systematic means to trim wild-grown omics studies in a constructive way. Nature Publishing Group UK 2022-10-21 /pmc/articles/PMC9587237/ /pubmed/36271093 http://dx.doi.org/10.1038/s41540-022-00251-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Emmert-Streib, Frank
Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title_full Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title_fullStr Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title_full_unstemmed Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title_short Severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
title_sort severe testing with high-dimensional omics data for enhancing biomedical scientific discovery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587237/
https://www.ncbi.nlm.nih.gov/pubmed/36271093
http://dx.doi.org/10.1038/s41540-022-00251-8
work_keys_str_mv AT emmertstreibfrank severetestingwithhighdimensionalomicsdataforenhancingbiomedicalscientificdiscovery